SFRP4 inhibits Wnt signaling pathway and decreases transcription of Wnt target genes, Axin2, CyclinD1 and Myc, reducing migration ability of ovarian cancer cells by increasing the ability to adhere to collagen and fibronectin (Ford et al., 2013). The gene discussed is AXIN2; the disease is ovarian carcinoma.